Vor Biopharma Inc. (VOR)
Largest Insider Buys in Sector
VOR Stock Price History Chart
VOR Stock Performance
About Vor Biopharma Inc.
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML blood cancer cells. The company's eHSCs targeted therapies, such as CAR-Ts, bispecific antibodies, and antibody-drug conjugates provide treatment for blood cancers. Vor Biopharma, Inc. has a collaboration agreement with Akron BioProducts to develop and manufacture cGMP nucleases. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Insider Activity of Vor Biopharma Inc.
Over the last 12 months, insiders at Vor Biopharma Inc. have bought $38.75M and sold $33,274 worth of Vor Biopharma Inc. stock.
On average, over the past 5 years, insiders at Vor Biopharma Inc. have bought $56.19M and sold $5.08M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Reprogrammed Interchange LLC (10 percent owner) — $38.75M.
The last purchase of 38,974,101 shares for transaction amount of $38.75M was made by Reprogrammed Interchange LLC (10 percent owner) on 2024‑12‑30.
List of Insider Buy and Sell Transactions, Vor Biopharma Inc.
| 2024-12-30 | 10 percent owner | 38.97M 44.4324% | $0.99 | $38.75M | +13.87% | |||
| 2024-12-27 | Sale | CHIEF MEDICAL OFFICER | 10,334 0.0158% | $1.25 | $12,918 | +5.51% | ||
| 2024-06-03 | Sale | CHIEF MEDICAL OFFICER | 14,645 0.0209% | $1.39 | $20,357 | -35.66% | ||
| 2021-11-16 | Sale | 330,706 0.7914% | $15.30 | $5.06M | -69.06% | |||
| 2021-11-16 | Sale | 10 percent owner | 330,706 0.7914% | $15.30 | $5.06M | -69.06% | ||
| 2021-02-09 | 2.98M 5.6047% | $18.00 | $53.63M | -63.24% | ||||
| 2021-02-09 | 555,555 1.045% | $18.00 | $10M | -63.24% | ||||
| 2021-02-09 | 10 percent owner | 555,555 1.045% | $18.00 | $10M | -63.24% |
Insider Historical Profitability
| Reprogrammed Interchange LLC | 10 percent owner | 38974101 56.7527% | $1.34 | 1 | 0 | |
| Attar Eyal C. | CHIEF MEDICAL OFFICER | 81439 0.1186% | $1.34 | 0 | 2 | |
| RA CAPITAL MANAGEMENT, L.P. | 8297265 12.0822% | $1.34 | 1 | 0 | <0.0001% | |
| PARMAR KUSH | 1766634 2.5725% | $1.34 | 1 | 1 | <0.0001% | |
| 5AM Ventures VI, L.P. | 10 percent owner | 1766634 2.5725% | $1.34 | 1 | 1 | <0.0001% |
Institutional Investor Ownership
| RA Capital Management, L.P. | $53.91M | 33.33 | 22.75M | 0% | +$0 | 0.05 | |
| Fidelity Investments | $18.03M | 11.15 | 7.61M | -0.14% | -$24,906.33 | <0.01 | |
| Paradigm BioCapital Advisors LP | $15.3M | 9.46 | 6.46M | 0% | +$0 | 0.56 | |
| 5Am Venture Management Llc | $15.08M | 9.32 | 6.36M | 0% | +$0 | 1.01 | |
| Laurion Capital Management LP | $7.54M | 4.66 | 3.18M | 0% | +$0 | 0.05 | |
| BlackRock | $5.33M | 3.29 | 2.25M | -0.18% | -$9,368.61 | <0.0001 | |
| The Vanguard Group | $4.3M | 2.66 | 1.81M | +3.98% | +$164,563.30 | <0.0001 | |
| Woodline Partners LP | $2.63M | 1.63 | 1.11M | 0% | +$0 | 0.02 | |
| Johnson & Johnson | $2.55M | 1.57 | 1.07M | 0% | +$0 | 0.06 | |
| Artal Group S A | $2.37M | 1.47 | 1M | -57.4% | -$3.19M | 0.01 | |
| Geode Capital Management | $1.99M | 1.23 | 841,208 | +5.94% | +$111,746.60 | <0.0001 | |
| State Street | $1.56M | 0.96 | 657,707 | +8.17% | +$117,789.03 | <0.0001 | |
| Sarissa Capital Management LP | $1.46M | 0.91 | 618,000 | 0% | +$0 | 0.26 | |
| Northern Trust | $944,118.00 | 0.58 | 398,362 | +0.29% | +$2,704.17 | <0.0001 | |
| MAI Capital Management, LLC | $867,086.00 | 0.54 | 365,859 | +2.44% | +$20,637.96 | 0.01 | |
| Ensign Peak Advisors Inc | $820,226.00 | 0.51 | 346,087 | 0% | +$0 | <0.01 | |
| Renaissance Technologies | $793,000.00 | 0.49 | 334,658 | +548.56% | +$670,729.50 | <0.01 | |
| Millennium Management LLC | $375,389.00 | 0.23 | 158,392 | New | +$375,389.00 | <0.0001 | |
| Exchange Traded Concepts, LLC | $366,013.00 | 0.23 | 154,436 | +156.67% | +$223,410.23 | 0.01 | |
| Bridgeway Capital Management | $314,499.00 | 0.19 | 132,700 | -18.44% | -$71,100.00 | 0.01 | |
| Morgan Stanley | $300,261.00 | 0.19 | 126,692 | -26.37% | -$107,524.87 | <0.0001 | |
| BNY Mellon | $247,787.00 | 0.15 | 104,551 | -3.38% | -$8,669.50 | <0.0001 | |
| Charles Schwab | $246,286.00 | 0.15 | 103,918 | 0% | +$0 | <0.0001 | |
| Goldman Sachs | $220,815.00 | 0.14 | 93,171 | +143.04% | +$129,958.79 | <0.0001 | |
| Marshall Wace | $180,864.00 | 0.11 | 76,314 | New | +$180,864.00 | <0.0001 | |
| Nuveen | $169,464.00 | 0.11 | 71,504 | 0% | +$0 | <0.0001 | |
| The Bollard Group | $132,000.00 | 0.08 | 55,555 | 0% | +$0 | <0.01 | |
| Acadian Asset Management | $126,000.00 | 0.08 | 53,708 | New | +$126,000.00 | <0.0001 | |
| Citadel Advisors LLC | $106,835.00 | 0.07 | 45,078 | +47.09% | +$34,203.89 | <0.0001 | |
| RhumbLine Advisers | $103,489.00 | 0.06 | 43,670 | +1.58% | +$1,611.46 | <0.0001 | |
| LMR PARTNERS LLP | $96,926.00 | 0.06 | 40,897 | -19.98% | -$24,207.21 | <0.01 | |
| Barclays | $91,000.00 | 0.06 | 38,475 | -26.12% | -$32,178.17 | <0.0001 | |
| UBS | $90,968.00 | 0.06 | 38,383 | +1.19% | +$1,066.50 | <0.0001 | |
| Deutsche Bank | $75,449.00 | 0.05 | 31,835 | 0% | +$0 | <0.0001 | |
| Bourgeon Capital Management, LLC. | $69,797.00 | 0.04 | 29,450 | 0% | +$0 | 0.01 | |
| Bank of America | $67,882.00 | 0.04 | 28,642 | -46.51% | -$59,011.03 | <0.0001 | |
| Susquehanna International Group | $62,997.00 | 0.04 | 26,581 | -58.19% | -$87,685.30 | <0.0001 | |
| Dimensional Fund Advisors | $59,058.00 | 0.04 | 24,919 | +21.64% | +$10,506.20 | <0.0001 | |
| Bank of Montreal | $53,297.00 | 0.03 | 22,488 | New | +$53,297.00 | <0.0001 | |
| New York State Common Retirement Fund | $52,000.00 | 0.03 | 21,867 | +1.73% | +$884.62 | <0.0001 | |
| Money Concepts | $47,400.00 | 0.03 | 20,000 | New | +$47,400.00 | 0.01 | |
| Jane Street Capital | $46,196.00 | 0.03 | 19,492 | +15.03% | +$6,036.39 | <0.0001 | |
| American International Group | $44,577.00 | 0.03 | 18,809 | +0.44% | +$194.34 | <0.0001 | |
| Xtx Topco Ltd | $44,189.00 | 0.03 | 18,645 | New | +$44,189.00 | <0.01 | |
| Chicago Partners Wealth Advisors | $33,942.00 | 0.03 | 18,054 | +4.24% | +$1,379.94 | <0.01 | |
| HSBC | $41,961.00 | 0.03 | 17,705 | New | +$41,961.00 | <0.0001 | |
| Invesco | $41,196.00 | 0.03 | 17,382 | -3.64% | -$1,554.74 | <0.0001 | |
| JPMorgan Chase | $38,363.00 | 0.02 | 16,187 | -33.92% | -$19,696.97 | <0.0001 | |
| Walleye Capital | $39,224.00 | 0.02 | 16,550 | New | +$39,224.00 | <0.0001 | |
| Voya Investment Management LLC | $34,761.00 | 0.02 | 14,667 | -7.72% | -$2,908.01 | <0.0001 |